نتایج جستجو برای: middle blockers

تعداد نتایج: 175301  

Journal: :Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2004
Ritsuko Miyajima Kazumi Sano Hisahiro Yoshida

To clarify contradictions in past reports and the package inserts for beta-adrenergic blocking agents (beta-blockers) for patients with intermittent claudication (IC), we investigated the effects of beta-blockers in patients with IC using the systematic review technique. Data sources were randomized, controlled trials that investigated the effects of beta-blockers compared with the placebo or u...

2017
Sean Duffy Robert Marron Helen Voelker Richard Albert John Connett William Bailey Richard Casaburi J. Allen Cooper Jeffrey L. Curtis Mark Dransfield MeiLan K. Han Barry Make Nathaniel Marchetti Fernando Martinez Stephen Lazarus Dennis Niewoehner Paul D. Scanlon Frank Sciurba Steven Scharf Robert M. Reed George Washko Prescott Woodruff Charlene McEvoy Shawn Aaron Don Sin Gerard J. Criner

BACKGROUND Beta-blockers are commonly prescribed for patients with cardiovascular disease. Providers have been wary of treating chronic obstructive pulmonary disease (COPD) patients with beta-blockers due to concern for bronchospasm, but retrospective studies have shown that cardio-selective beta-blockers are safe in COPD and possibly beneficial. However, these benefits may reflect symptom impr...

2014
Yoshiyuki Morishita Eiji Kusano Daisuke Nagata

The renin-angiotensin-aldosterone system (RAAS) blockers have been widely used in chronic kidney disease patients undergoing hemodialysis; however, whether RAAS blockers have beneficial effects for cardiovascular disease in those patients has not been fully defined. This review focuses on the effects of RAAS blockers in chronic kidney disease undergoing hemodialysis for cardiovascular disease.

Journal: :iranian red crescent medical journal 0
a serhat emergency medicine clinic,i{m{rbo{ykkatvsioooogaondrwwwesskhhosy}umlizmir, turkey +90-505-7079350, [email protected]; emergency medicine clinic,i{m{rbo{ykkatvsioooogaondrwwwesskhhosy}umlizmir, turkey +90-505-7079350, [email protected] hayriye gonullu deparment of emergency medicine, van yuzuncuyil university, turkey a huriye emergency medicine clinic,i{m{rbo{ykkatvsioooogaondrwwwesskhhosy}umlizmir, turkey +90-505-7079350, [email protected]

background calcium infusion is used as a pre-treatment before calcium channel blockers to prevent hypotension. occasional cardioversion with calcium gluconate infusion is seen in patients with paroxysmal supraventricular tachycardia. several mechanisms have been suggested for mechanism. herein we report a case presenting with atrial fibrillation but cardioverted with calcium gluconate infusion,...

Journal: :Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 2008
Danai Tsalta Emmanuel Anastasakis Dimitrios E Papadogiannis

B eta-adrenergic blockers have been widely used as first-line drugs in the treatment of idiopathic arterial hypertension for around 40 years. Recent meta-analyses, however, suggest that they are significantly inferior to other categories of drugs (thiazide diuretics, calcium channel blockers, angiotensin converting enzyme [ACE] inhibitors, angiotensin II receptor blockers). This observation has...

Journal: :Clinical cardiology 1989
O Fukyama

Calcium channel blockers are important drugs for the treatment of chronic stable angina. However, negative inotropic and dromotropic effects may limit their usefulness in patients with atrioventricular conduction abnormalities or left ventricular dysfunction. A new generation of calcium channel blockers will soon be available that have a more vascular selective action than currently available a...

2016
Hassan Fares James J DiNicolantonio James H O'Keefe Carl J Lavie

OBJECTIVES Hypertension is well established as a major risk factor for cardiovascular disease. Although there is undeniable evidence to support the beneficial effects of antihypertensive therapy on morbidity and mortality, adequate blood pressure management still remains suboptimal. Research into the treatment of hypertension has produced a multitude of drug classes with different efficacy prof...

Journal: :Biology, Medicine & Natural Product Chemistry 2023

The novel coronavirus (CoV) severe acute respiratory syndrome (SARS)-CoV-2 outbreak began at the end of 2019 in Wuhan, China, and has spread to over 200 countries. Many comorbidities have shown be associated with severity viral infection hypertension being one highest rated since loss ACE2 receptor due SARS-Cov-2 can lead increased blood pressure. effects clinical characteristics use beta-block...

Journal: :arya atherosclerosis 0
mojgan gharipour abdolmehdi baghaei katayun rabiei nizal sarrafzadegan

abstract introduction: cardiovascular diseases (cvd) and cerebrovascular diseases (cevd) are a large and growing problem in low- and middle-income populations. secondary prevention, which can reduce the risk of recurrent cvd includes changes in lifestyle, pharmacological interventions and revascularization procedures. the aim of the first phase of this project was to perform situation analysis ...

2003
Vijay C. Swamy David J. Triggle

The agents commonly called the calcium channel blockers comprise an increasing number of agents, including the prototypical verapamil (Calan, Isoptin), nifedipine (Adalat, Procardia), and diltiazem (Cardizem). These agents are a chemically and pharmacologically heterogeneous group of synthetic drugs, but they possess the common property of selectively antagonizing Ca movements that underlie the...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید